Daniel Dybdal1,2, Janne S Tolstrup2, Stine M Sildorf3, Kirsten A Boisen4, Jannet Svensson3, Anne Mette Skovgaard2,5, Grete K Teilmann6. 1. Department of Paediatrics and Adolescent Medicine, Nordsjællands Hospital, Dyrehavevej 29, DK 3400, Hillerød, Denmark. 2. National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark. 3. Department of Paediatrics and Adolescent Medicine, Herlev Hospital, Herlev, Denmark. 4. Centre of Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark. 5. Institute of Public Health, University of Copenhagen, Copenhagen, Denmark. 6. Department of Paediatrics and Adolescent Medicine, Nordsjællands Hospital, Dyrehavevej 29, DK 3400, Hillerød, Denmark. grete.katrine.teilmann@regionh.dk.
Abstract
AIMS/HYPOTHESIS: The aim of this study was to investigate psychiatric morbidity following childhood onset of type 1 diabetes. METHODS: In a matched, population-based cohort study based on Danish national registers, we identified children and adolescents who had been diagnosed as an in- or outpatient with type 1 diabetes before the age of 18, and afterwards diagnosed with a psychiatric disorder (n = 5084). Control individuals were matched according to sex and date of birth (n = 35,588). The Cox proportional hazards model was used to assess associations between type 1 diabetes and the incidence of psychiatric disorders as well as the effects of age at onset and duration of type 1 diabetes on the risk of subsequently developing psychiatric morbidities. RESULTS: An increased risk of being diagnosed with mood disorders and anxiety, dissociative, eating, stress-related and somatoform disorders was observed in both sexes in the years following type 1 diabetes onset, with the highest risk observed five years or more after onset (HR 1.55 [95% CI 1.38, 1.74]). The risk of psychoactive substance-misuse disorders increased significantly only in boys, and the risk of personality disorders increased only in girls. CONCLUSIONS/ INTERPRETATION: In the years following type 1 diabetes onset, an increased risk of eating disorders, anxiety and mood disorders, substance misuse, and personality disorders was found. These findings highlight a clinical need to monitor the mental health of children and adolescents in the years following type 1 diabetes onset to identify and treat psychiatric problems associated with type 1 diabetes.
AIMS/HYPOTHESIS: The aim of this study was to investigate psychiatric morbidity following childhood onset of type 1 diabetes. METHODS: In a matched, population-based cohort study based on Danish national registers, we identified children and adolescents who had been diagnosed as an in- or outpatient with type 1 diabetes before the age of 18, and afterwards diagnosed with a psychiatric disorder (n = 5084). Control individuals were matched according to sex and date of birth (n = 35,588). The Cox proportional hazards model was used to assess associations between type 1 diabetes and the incidence of psychiatric disorders as well as the effects of age at onset and duration of type 1 diabetes on the risk of subsequently developing psychiatric morbidities. RESULTS: An increased risk of being diagnosed with mood disorders and anxiety, dissociative, eating, stress-related and somatoform disorders was observed in both sexes in the years following type 1 diabetes onset, with the highest risk observed five years or more after onset (HR 1.55 [95% CI 1.38, 1.74]). The risk of psychoactive substance-misuse disorders increased significantly only in boys, and the risk of personality disorders increased only in girls. CONCLUSIONS/ INTERPRETATION: In the years following type 1 diabetes onset, an increased risk of eating disorders, anxiety and mood disorders, substance misuse, and personality disorders was found. These findings highlight a clinical need to monitor the mental health of children and adolescents in the years following type 1 diabetes onset to identify and treat psychiatric problems associated with type 1 diabetes.
Authors: Shengxin Liu; Ralf Kuja-Halkola; Henrik Larsson; Paul Lichtenstein; Jonas F Ludvigsson; Ann-Marie Svensson; Soffia Gudbjörnsdottir; Magnus Tideman; Eva Serlachius; Agnieszka Butwicka Journal: Diabetologia Date: 2021-01-16 Impact factor: 10.122
Authors: Paul F Seke Etet; Muaawia A Hamza; Ahmed El-Tahir; Lorella Vecchio; Sayed Y Osman; Gwiria M H Satti; Mohamed H A Ismail; Mohammed Farahna; Alfred K Njamnshi; Abdu Adem Journal: Evid Based Complement Alternat Med Date: 2022-03-21 Impact factor: 2.629
Authors: Shengxin Liu; Marica Leone; Jonas F Ludvigsson; Paul Lichtenstein; Brian D'Onofrio; Ann-Marie Svensson; Soffia Gudbjörnsdottir; Sarah E Bergen; Henrik Larsson; Ralf Kuja-Halkola; Agnieszka Butwicka Journal: Diabetes Care Date: 2022-09-01 Impact factor: 17.152